Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Unlocking Better Communication: Insights from Recent Research on Oromandibular Dystonia

Unlocking Better Communication: Insights from Recent Research on Oromandibular Dystonia

As practitioners dedicated to improving communication outcomes for children, it is essential to stay abreast of the latest research and apply data-driven decisions in our therapeutic approaches. A recent study titled Examining Speech Intelligibility and Self-Ratings of Communicative Effectiveness in Speakers With Oromandibular Dystonia Receiving Botulinum Toxin Therapy provides valuable insights that can enhance our understanding and treatment of speech production deficits in patients with oromandibular dystonia (OMD).

OMD is a focal dystonia affecting the mouth and face regions, leading to dysarthria and reduced speech intelligibility. This study investigated the effects of Botulinum toxin type A (BoNT-A) injections on speech intelligibility and self-ratings of communicative effectiveness in individuals with OMD.

Key Findings from the Study

Implications for Practice

Despite the non-significant overall results, the study highlights several critical areas for practitioners:

Conclusion

This study underscores the complexity of treating speech production deficits in OMD and the importance of individualized, data-driven therapeutic strategies. By integrating these findings into practice, practitioners can better address the unique needs of their patients and potentially improve communication outcomes.

To read the original research paper, please follow this link: Examining Speech Intelligibility and Self-Ratings of Communicative Effectiveness in Speakers With Oromandibular Dystonia Receiving Botulinum Toxin Therapy.


Citation: Dykstra, A. D., Domingo, Y., Adams, S. G., & Jog, M. (2015). Examining Speech Intelligibility and Self-Ratings of Communicative Effectiveness in Speakers With Oromandibular Dystonia Receiving Botulinum Toxin Therapy. Canadian Journal of Speech-Language Pathology and Audiology, 39(4), 334-345.
Marnee Brick, President, TinyEYE Therapy Services

Author's Note: Marnee Brick, TinyEYE President, and her team collaborate to create our blogs. They share their insights and expertise in the field of Speech-Language Pathology, Online Therapy Services and Academic Research.

Connect with Marnee on LinkedIn to stay updated on the latest in Speech-Language Pathology and Online Therapy Services.

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP

Apply Today

If you are looking for a rewarding career
in online therapy apply today!

APPLY NOW

Sign Up For a Demo Today

Does your school need
Online Therapy Services

SIGN UP